Duquesne Family Office’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-169,350	Closed	-$27.2M	–	76
2020 Q2	$27.2M	Buy	+169,350	New	+$27.2M	0.83%	30